A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories

Open Access

Peer-reviewed

Research Article

Matthew E. Falagas ,

*To whom correspondence should be addressed. E-mail: matthew.falagas@tufts.edu

Affiliations Alfa Institute of Biomedical Sciences, Athens, Greece, Department of Medicine, “Henry Dunant” Hospital, Athens, Greece, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America
⨯
Konstantinos N. Fragoulis,

Affiliations Alfa Institute of Biomedical Sciences, Athens, Greece, Department of Medicine, “Henry Dunant” Hospital, Athens, Greece
⨯
Ioannis Karydis

Affiliation Alfa Institute of Biomedical Sciences, Athens, Greece
⨯

Reader Comments (0)

Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Antimicrobials
Is the Subject Area "Antimicrobials" applicable to this article?

Thanks for your feedback.
Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.
Drugs
Is the Subject Area "Drugs" applicable to this article?

Thanks for your feedback.
Immunosuppressives
Is the Subject Area "Immunosuppressives" applicable to this article?

Thanks for your feedback.
Infectious diseases
Is the Subject Area "Infectious diseases" applicable to this article?

Thanks for your feedback.